Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia

Clinical Proteomics

Volumn 11, Issue 1, 2014, Pages

  Baig, Sonia ^a   Kothandaraman, Narasimhan ^a   Manikandan, Jayapal ^a   Rong, Li ^c   Ee, Kim Huey ^c   Hill, Jeffrey ^c   Lai, Chin Wee ^a   Tan, Wan Yu ^a   Yeoh, Felicia ^a   Kale, Anita ^a   Su, Lin Lin ^a   Biswas, Arijit ^a   Vasoo, Sheila ^b   Choolani, Mahesh ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Dept Medicine Endocrinol Diabet   (Singapore)

^c Agency for Science   (Singapore)

Author keywords

Placental microvesicles; Preeclampsia; Pregnancy; Proteome

Indexed keywords

ANNEXIN; HISTONE; INTEGRIN;

ADULT; ARTICLE; CONTROLLED STUDY; EXPLANT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE VESICLE; PLACENTA; PLACENTAL SYNCYTIOTROPHOBLAST MICROVESICLE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SUPERNATANT; SYNCYTIOTROPHOBLAST; TANDEM MASS SPECTROMETRY; TISSUE CULTURE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION PROCESS;

EID: 84920397447     PISSN: 15426416     EISSN: 15590275     Source Type: Journal    
DOI: 10.1186/1559-0275-11-40     Document Type: Article

References (45)

1. Gupta AK, Holzgreve W, Hahn S: Decrease in lipid levels of syncytiotrophoblast micro- particles reduced their potential to inhibit endothelial cell proliferation. Arch Gynecol Obstet 2008, 277:115-119. 10.1007/s00404-007-0425-2
2. Cocucci E, Racchetti G, Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51. 10.1016/j.tcb.2008.11.003
3. Redman CW, Tannetta DS, Dragovic RA, Gardiner C, Southcombe JH, Collett GP, Sargent IL: Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012,33(Suppl):S48-S54.
4. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA: Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 2012, 59:256-264. 10.1161/HYPERTENSIONAHA.111.182170
5. Knight M, Redman CW, Linton EA, Sargent IL: Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998, 105:632-640. 10.1111/j.1471-0528.1998.tb10178.x
6. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007, 178:5949-5956. 10.4049/jimmunol.178.9.5949
7. Messerli M, May K, Hansson SR, Schneider H, Holzgreve W, Hahn S, Rusterholz C: Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 2009, 31:106-112.
8. Southcombe J, Tannetta D, Redman C, Sargent I: The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One 2011, 6:e20245. 10.1371/journal.pone.0020245
9. Gardiner C, Tannetta DS, Simms CA, Harrison P, Redman CW, Sargent IL: Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One 2011, 6:e26313. 10.1371/journal.pone.0026313
10. Smarason AK, Sargent IL, Starkey PM, Redman CW: The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993, 100:943-949. 10.1111/j.1471-0528.1993.tb15114.x
11. Gupta AK, Rusterholz C, Holzgreve W, Hahn S: Syncytiotrophoblast micro-particles do not induce apoptosis in peripheral T lymphocytes, but differ in their activity depending on the mode of preparation. J Reprod Immunol 2005, 68:15-26. 10.1016/j.jri.2005.05.003
12. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF: The platelet microparticle proteome. J Proteome Res 2005, 4:1516-1521. 10.1021/pr0500760
13. Jin M, Drwal G, Bourgeois T, Saltz J, Wu HM: Distinct proteome features of plasma microparticles. Proteomics 2005, 5:1940-1952. 10.1002/pmic.200401057
14. Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L: Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics 2006, 6:153-171. 10.1002/pmic.200500133
15. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W: Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003, 278:10963-10972. 10.1074/jbc.M207550200
16. Thery C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S: Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999, 147:599-610. 10.1083/jcb.147.3.599
17. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S: Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001, 166:7309-7318. 10.4049/jimmunol.166.12.7309
18. van Niel G, Raposo G, Candalh C, Boussac M, Hershberg R, Cerf-Bensussan N, Heyman M: Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001, 121:337-349. 10.1053/gast.2001.26263
19. Thery C, Zitvogel L, Amigorena S: Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
20. Nickel W: Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 2005, 6:607-614. 10.1111/j.1600-0854.2005.00302.x
21. Roberts JM, Lain KY: Recent Insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359-372. 10.1053/plac.2002.0819
22. Serdar Z, Gur E, Colakoethullary M, Develioethlu O, Sarandol E: Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 2003, 268:19-25.
23. Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E: Proteome differences of placenta between pre-eclampsia and normal pregnancy. Placenta 2009, 31:121-125.
24. Okamura K, Powell JE, Lee AC, Stevens VC: Characterization of solubilized microvillous membrane proteins and glycoproteins from human placental syncytiotrophoblast. Placenta 1981, 2:117-128. 10.1016/S0143-4004(81)80015-X
25. Hu R, Jin H, Zhou S, Yang P, Li X: Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo. Placenta 2007, 28:399-407. 10.1016/j.placenta.2006.07.005
26. Johnstone ED, Sawicki G, Guilbert L, Winkler-Lowen B, Cadete VJ, Morrish DW: Differential proteomic analysis of highly purified placental cytotrophoblasts in pre-eclampsia demonstrates a state of increased oxidative stress and reduced cytotrophoblast antioxidant defense. Proteomics 2011, 11:4077-4084. 10.1002/pmic.201000505
27. Epiney M, Ribaux P, Arboit P, Irion O, Cohen O: Comparative analysis of secreted proteins from normal and preeclamptic trophoblastic cells using proteomic approaches. J Proteomics 2012, 75:1771-1777. 10.1016/j.jprot.2011.12.021
28. Menkhorst EM, Lane N, Winship AL, Li P, Yap J, Meehan K, Rainczuk A, Stephens A, Dimitriadis E: Decidual secreted factors alter invasive trophoblast membrane and secreted proteins implying a role for decidual cell regulation of placentation. PLoS One 2012, 7:e31418. 10.1371/journal.pone.0031418
29. Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R, Cooney J, McCowan LM, Cooper GJ, North RA: A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics 2009, 9:2929-2945. 10.1002/pmic.200800625
30. Liu C, Zhang N, Yu H, Chen Y, Liang Y, Deng H, Zhang Z: Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta 2010, 32:168-174.
31. Shin JK, Baek JC, Kang MY, Park JK, Lee SA, Lee JH, Choi WS, Paik WY: Proteomic analysis reveals an elevated expression of heat shock protein 27 in preeclamptic placentas. Gynecol Obstet Invest 2011, 71:151-157. 10.1159/000315162
32. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, Harrison P, Sargent IL: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 2011, 7:780-788. 10.1016/j.nano.2011.04.003
33. Takahashi S, Reddy SV, Chirgwin JM, Devlin R, Haipek C, Anderson J, Roodman GD: Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem 1994, 269:28696-28701.
34. El Kebir D, Jozsef L, Filep JG: Opposing regulation of neutrophil apoptosis through the formyl peptide receptor-like 1/lipoxin A4 receptor: implications for resolution of inflammation. J Leukoc Biol 2008, 84:600-606. 10.1189/jlb.1107765
35. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N, Zamzami N, Jan G, Kroemer G, Brenner C: GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 2007, 26:2606-2620. 10.1038/sj.onc.1210074
36. Zala D, Hinckelmann MV, Yu H, da Cunha MM L, Liot G, Cordelières FP, Marco S, Saudou F: Vesicular glycolysis provides on-board energy for fast axonal transport. Cell 2013, 152:479-491. 10.1016/j.cell.2012.12.029
37. Huang Y, Qiao F, Abagyan R, Hazard S, Tomlinson S: Defining the CD59-C9 binding interaction. J Biol Chem 2006, 281:27398-27404. 10.1074/jbc.M603690200
38. Murai JT, Muzykanskiy E, Taylor RN: Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 1997, 46:963-967. 10.1016/S0026-0495(97)90088-3
39. Redfern CH, Degtyarev MY, Kwa AT, Salomonis N, Cotte N, Nanevicz T, Fidelman N, Desai K, Vranizan K, Lee EK, Coward P, Shah N, Warrington JA, Fishman GI, Bernstein D, Baker AJ, Conklin BR: Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc Natl Acad Sci U S A 2000, 97:4826-4831. 10.1073/pnas.97.9.4826
40. Huppertz B, Berghold VM, Kawaguchi R, Gauster M: A variety of opportunities for immune interactions during trophoblast development and invasion. Am J Reprod Immunol 2012, 67:349-357. 10.1111/j.1600-0897.2012.01124.x
41. Granés F, Urena JM, Rocamora N, Vilaró S: Ezrin links syndecan-2 to the cytoskeleton. J Cell Sci 2000, 113:1267-1276.
42. Yun CH, Lamprecht G, Forster DV, Sidor A: NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H∈+∈exchanger NHE3 and the cytoskeletal protein ezrin. J Biol Chem 1998, 273:25856-25863. 10.1074/jbc.273.40.25856
43. Benoit C, Zavecz J, Wang Y: Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta 2007, 28:498-504. 10.1016/j.placenta.2006.09.002
44. Liang D, Burkhart SL, Singh RK, Kabbaj MH, Gunjan A: Histone dosage regulates DNA damage sensitivity in a checkpoint-independent manner by the homologous recombination pathway. Nucleic Acids Res 2012, 40:9604-9620. 10.1093/nar/gks722
45. Baig S, Lim JY, Fernandis AZ, Wenk MR, Kale A, Su LL, Biswas A, Vasoo S, Shui G, Choolani M: Lipidomic analysis of human placental Syncytiotrophoblast microvesicles in adverse pregnancy outcomes. Placenta 2013, 34:436-442. 10.1016/j.placenta.2013.02.004